Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments
Source
The journal of clinical investigation - ISSN 0021-9738-133:6 (2023) p. 1-14
Clinical impact of monoclonal antibodies in the treatment of high-risk patients with SARS-CoV-2 breakthrough infections : the ORCHESTRA prospective cohort study
Source
Biomedicines - ISSN 2227-9059-10:9 (2022) p. 1-12
Clinical efficacy of different monoclonal antibody regimens among non-hospitalised patients with mild to moderate COVID-19 at high risk for disease progression : a prospective cohort study
Source
European journal of clinical microbiology and infectious diseases - ISSN 0934-9723-41:7 (2022) p. 1065-1076
Detection of SARS-CoV-2 in young children attending day-care centres in Belgium, May 2020 to February 2022
Source
Eurosurveillance : European communicable disease bulletin - ISSN 1025-496X-27:21 (2022) p. 1-5